Cargando…
Multi-small molecule conjugations as new targeted delivery carriers for tumor therapy
In response to the challenges of cancer chemotherapeutics, including poor physicochemical properties, low tumor targeting ability, and harmful side effects, we developed a new tumor-targeted multi-small molecule drug delivery platform. Using paclitaxel (PTX) as a model therapeutic, we prepared two p...
Autores principales: | Shan, Lingling, Liu, Ming, Wu, Chao, Zhao, Liang, Li, Siwen, Xu, Lisheng, Cao, Wengen, Gao, Guizhen, Gu, Yueqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562733/ https://www.ncbi.nlm.nih.gov/pubmed/26366078 http://dx.doi.org/10.2147/IJN.S85402 |
Ejemplares similares
-
A Bifurcated Proteoglycan Binding Small Molecule Carrier for siRNA Delivery
por: Gooding, Matt, et al.
Publicado: (2014) -
The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy
por: Li, Siwen, et al.
Publicado: (2014) -
Macromolecular Conjugate and Biological Carrier Approaches for the Targeted Delivery of Antibiotics
por: Tram, Nhan Dai Thien, et al.
Publicado: (2017) -
Cellular delivery of dinucleotides by conjugation with small molecules: targeting translation initiation for anticancer applications
por: Kleczewska, Natalia, et al.
Publicado: (2021) -
Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023)